Table 3 Clinical characteristics of genotyped samples from the pediatric cohort of asthma. (FEV1 : Forced Expiratory Volume in one second, FVC : Forced vital capacity, MEF25: Maximum expiratory flow at 25% of FVC, MEF75 : Maximum expiratory flow at 75% of FVC, PEFR : Peak expiratory flow rate, A: ANOVA, K: Kruskal Wallis).
From: Genetic variations in olfactory receptor gene OR2AG2 in a large multigenerational family with asthma
Variable | GG (n = 57) | GC (n = 58) | CC (n = 26) | Statistical Test |
|---|---|---|---|---|
Mean (SD) | Mean (SD) | Mean (SD) | p-value *(A/K) | |
Age (Months) | 106.88 (42.09) | 101.36 (38.20) | 106.50 (38.36) | 0.73 (A) |
Exhaled Nitric Oxide (PPB) | 24.65 (19.66) | 18.89 (11.95) | 16.77 (9.56) | 0.28 (K) |
FEV1 (% predicted) | 89.2 (18.76) | 83.28 (19.02) | 83.33 (17.70) | 0.27 (A) |
FVC (% predicted) | 86.96 (15.99) | 81.93 (16.34) | 82.10 (17.48) | 0.30 (A) |
MEF25 (% predicted) | 79.43 (48.19) | 77.86 (40.62) | 89.57 (48.24) | 0.75 (K) |
MEF75 (% predicted) | 91.58 (29.69) | 84.32 (30.25) | 84.67 (29.83) | 0.47 (A) |
PEFR (% predicted) | 74.48 (20.65) | 67.43 (24.14) | 69.05 (20.07) | 0.29 (A) |
Exacerbation Frequency | 0.13 (0.14) | 0.20 (0.22) | 0.16 (0.12) | 0.30 (K) |
Smell Test PEA | 8.4 (3.09) | 7.04 (3.39) | 6.48 (3.63) | 0.19 (A) |
